Drug

Ifenprodil clinical trials

studies test it: 4
open now: 1
in phase 3: 1
first study started: 2014

How each study uses ifenprodil is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the ifenprodil studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Approvals

The first approval found in each region, with its record

United States: Not in FDA's approval records
European Union: Not in EMA's list of EU-wide authorisations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Ifenprodil: 2

Studies by the year they started

4 studies that test it; most in 2020 (2)

Studies that test ifenprodil, by start year
Year	Studies
2014	1
2020	2
2024	1

By phase

A phase 1/2 study counts in both.

Phase 1: 1
Phase 2: 4
Phase 3: 1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Idiopathic Pulmonary Fibrosis: 1
Stress Disorders, Post-Traumatic: 1
Multiple Sclerosis, Relapsing-Remitting: 1

Who runs them

Industry 2 · Other 2

Algernon Pharmaceuticals (2) · Chiba University (1) · Assistance Publique - Hôpitaux de Paris (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test ifenprodil.

Mar 2027Ifenprodil as a ReMyelinating repurpOsed Drug in Multiple SclerosisPhase 2 · Assistance Publique - Hôpitaux de Paris

Studies

Open first, then newest update. How each study uses ifenprodil is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 4

Codes

What other systems call ifenprodil · ClinicalTrials.gg INT002501

MeSH (NLM) C010739ifenprodilConfirmed ClinicalTrials.gov, NLM, Wikidata
UNII (FDA) R8OE3P6O5SIFENPRODILConfirmed FDA, NLM, Wikidata
RxNorm 27403Confirmed FDA, Wikidata
Wikidata Q5991156ifenprodilConfirmed FDA, NLM, Wikidata
NCI Thesaurus C83782IfenprodilOne source FDA
DrugBank DB08954One source Wikidata

System	Code	Name there	Checked by
MeSH (NLM)	C010739	ifenprodil	Confirmed ClinicalTrials.gov, NLM, Wikidata
UNII (FDA)	R8OE3P6O5S	IFENPRODIL	Confirmed FDA, NLM, Wikidata
RxNorm	27403	—	Confirmed FDA, Wikidata
Wikidata	Q5991156	ifenprodil	Confirmed FDA, NLM, Wikidata
NCI Thesaurus	C83782	Ifenprodil	One source FDA
DrugBank	DB08954	—	One source Wikidata

Also registered as ifenprodil tartrate (UNII 89CTB4XUF7 · RxNorm 289912).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.